<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9</volume><submitter>Chen YH</submitter><pubmed_abstract>&lt;h4>Objectives&lt;/h4>The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) has been widely utilized to evaluate disease activity in patients with ankylosing spondylitis (AS) by an arbitrary cut-off of ≥4 to indicate high disease activity and initiate biological therapy. The Ankylosing Spondylitis Disease Activity Score (ASDAS) is a new composite index to assess AS disease activity states that have been defined and validated. ASDAS ≥2.1 was selected as a criterion to start biological therapy. The purpose of this study was to estimate the corresponding BASDAI and ASDAS cut-off in a Taiwanese AS cohort.&lt;h4>Methods&lt;/h4>From November 2016 to October 2018, we assessed the ASDAS and the BASDAI regularly and recorded demographic data for 489 AS patients in Taichung Veterans General hospita</pubmed_abstract><journal>Frontiers in medicine</journal><pagination>856654</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9149077</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The BASDAI Cut-Off for Disease Activity Corresponding to the ASDAS Scores in a Taiwanese Cohort of Ankylosing Spondylitis.</pubmed_title><pmcid>PMC9149077</pmcid><pubmed_authors>Liao YW</pubmed_authors><pubmed_authors>Hsieh TY</pubmed_authors><pubmed_authors>Chen HH</pubmed_authors><pubmed_authors>Lin CT</pubmed_authors><pubmed_authors>Tang KT</pubmed_authors><pubmed_authors>Hung WT</pubmed_authors><pubmed_authors>Wu YD</pubmed_authors><pubmed_authors>Tseng CW</pubmed_authors><pubmed_authors>Huang CY</pubmed_authors><pubmed_authors>Chen YJ</pubmed_authors><pubmed_authors>Chen YH</pubmed_authors><pubmed_authors>Lai KL</pubmed_authors><pubmed_authors>Huang WN</pubmed_authors><pubmed_authors>Chen YM</pubmed_authors><pubmed_authors>Chou YY</pubmed_authors><pubmed_authors>Hsieh CW</pubmed_authors></additional><is_claimable>false</is_claimable><name>The BASDAI Cut-Off for Disease Activity Corresponding to the ASDAS Scores in a Taiwanese Cohort of Ankylosing Spondylitis.</name><description>&lt;h4>Objectives&lt;/h4>The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) has been widely utilized to evaluate disease activity in patients with ankylosing spondylitis (AS) by an arbitrary cut-off of ≥4 to indicate high disease activity and initiate biological therapy. The Ankylosing Spondylitis Disease Activity Score (ASDAS) is a new composite index to assess AS disease activity states that have been defined and validated. ASDAS ≥2.1 was selected as a criterion to start biological therapy. The purpose of this study was to estimate the corresponding BASDAI and ASDAS cut-off in a Taiwanese AS cohort.&lt;h4>Methods&lt;/h4>From November 2016 to October 2018, we assessed the ASDAS and the BASDAI regularly and recorded demographic data for 489 AS patients in Taichung Veterans General hospita</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-26T07:31:04.199Z</modification><creation>2025-04-06T12:17:13.536Z</creation></dates><accession>S-EPMC9149077</accession><cross_references><pubmed>35652077</pubmed><doi>10.3389/fmed.2022.856654</doi></cross_references></HashMap>